CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
| Bid date, 2022-11-15 | |
| Auction date | 2022-11-15 |
| Settlement date | 2022-11-16 |
| Maturity Date | 2022-11-23 |
| Nominal amount | 584 billion SEK |
| Interest rate, % | 1.75 |
| Bid times | 09.30-10.00 (CET/CEST) on the Bid date |
| Confirmation of bids to e-mail | rbcert@riksbank.se |
| The lowest accepted bid volume | 1 million SEK |
| The highest accepted bid volume | 584 billion SEK |
| Allocation Time | 10.15 (CET/CEST) on the Bid date |
| Projected minimum liquidity surplus during the term | 1167 billion SEK |
| Expected excess liquidity at full allotment | 583 billion SEK |
Stockholm, 2022-11-15
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Kreditbanken A/S: rapport for 1.kvartal 20248.5.2024 15:51:39 CEST | pressemeddelelse
Kreditbanken A/S: rapport for 1.kvartal 2024 Vedhæftet fil Meddelelse 6 2024
Trading by management and close relations of management8.5.2024 15:21:32 CEST | Press release
Please read the full announcement in PDF Attachment 2024_16_Trading_By_Management
ABG Sundal Collier Initiates Coverage of CoinShares International Limited8.5.2024 15:21:20 CEST | Press release
8th May 2024 | SAINT HELIER, Jersey | CoinShares International Limited (“CoinShares'' or “the Group”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF), the leading European investment company specialising in digital assets, is pleased to announce that ABG Sundal Collier has initiated coverage of the Company. Click here to view the full report or here to download the report. ABOUT COINSHARES CoinShares is the leading European investment company specialising in digital assets, that delivers a broad range of financial services across investment management, trading and securities to a wide array of clients that includes corporations, financial institutions and individuals. Focusing on crypto since 2013, the firm is headquartered in Jersey, with offices in France, Sweden, Switzerland, the UK and the US. CoinShares is regulated in Jersey by the Jersey Financial Services Commission, in France by the Autorité des marchés financiers, and in the US by the Financial Industry Regulatory Authority. CoinShar
Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S8.5.2024 15:16:55 CEST | Press release
8 May 2024 Announcement No. 16 Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S In continuation of company announcement no. 15 of 8 May 2024 regarding notice of an extraordinary general meeting, to be held on 3 June 2024. with a view to reducing the company's capital, the Board of Directors of Pharma Equity Group A/S ("PEG") has today decided to explore the possibilities of strengthening PEG's working capital through a capital increase at market price. Any directed capital increase will be expected to be carried out without a prospectus being prepared due to the expected size of the capital increase. Any capital increase will be subject to the adoption of the capital reduction. The specific details of a possible capital increase will be published when and if the Board of Directors decides to do so. For further information, please contact: Thomas Kaas Selsø, CEO of Pharma Equity Group A/S, phone: +45 4022 2114 Christian Vinding Thom
Afsøgning af muligheder angående en rettet kapitalforhøjelse til markedskurs i Pharma Equity Group A/S8.5.2024 15:16:55 CEST | pressemeddelelse
8. maj 2024 Meddelelse nr. 16 Afsøgning af muligheder angående en rettet kapitalforhøjelse til markedskurs i Pharma Equity Group A/S I forlængelse af selskabsmeddelelse nr. 15 fra 8. maj 2024 angående indkaldelse til en ekstraordinær generalforsamling den 3. juni 2024 med henblik på at nedsætte selskabets kapital, har bestyrelsen i Pharma Equity Group A/S ("PEG") i dag truffet beslutning om at afsøge mulighederne for at styrke PEG's arbejdskapital ved en kapitalforhøjelse til markedspris. En eventuel rettet kapitalforhøjelse vil forventeligt blive gennemført uden, at der udarbejdes et prospekt grundet kapitalforhøjelses forventede størrelse. En eventuel kapitalforhøjelse vil forudsætte, at kapitalnedsættelsen vedtages. De konkrete detaljer omkring en eventuel kapitalforhøjelse vil blive offentliggjort når og hvis bestyrelsen måtte træffe beslutning herom. For yderligere information, kontakt venligst: Thomas Kaas Selsø, adm. direktør i Pharma Equity Group A/S, telefon: +45 4022 2114 Chr